Vericel Corporation (VCEL)
NASDAQ: VCEL
· Real-Time Price · USD
43.49
0.32 (0.74%)
At close: Jun 05, 2025, 3:59 PM
43.40
-0.21%
After-hours: Jun 05, 2025, 04:20 PM EDT
Vericel Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| MACI Implants And Kits Revenue | 197.31M | 164.8M | 131.97M | 111.55M |
| MACI Implants And Kits Revenue Growth | +19.73% | +24.88% | +18.30% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 41.8M | 35.1M | 38.02M | 35.27M | 34.4M | 30.88M | 29.99M | 30.65M | 29.48M | 26.92M | 26.98M | 27.14M | 25.86M | 25.97M | 22.77M | 26.19M | 22.66M | 18.24M | 16.04M | 16.49M | 18.07M | 16.38M | 14.98M | 16.26M | 13.52M | 13.69M | 12.57M | 11.79M | 10.95M | 10.18M | 8.19M | 8.83M | 8.41M | 7.92M | 7.01M | 6.45M | 6M | 5.74M | 5.67M | 5.58M | 5.48M |
| Selling, General, and Administrative Revenue Growth | +19.11% | -7.70% | +7.81% | +2.53% | +11.42% | +2.95% | -2.15% | +3.95% | +9.53% | -0.21% | -0.62% | +4.94% | -0.39% | +14.02% | -13.04% | +15.58% | +24.23% | +13.71% | -2.70% | -8.76% | +10.32% | +9.32% | -7.85% | +20.26% | -1.26% | +8.94% | +6.60% | +7.64% | +7.57% | +24.40% | -7.32% | +5.05% | +6.09% | +13.05% | +8.70% | +7.41% | +4.53% | +1.23% | +1.59% | +1.99% | n/a |
| Research and Development Revenue | 7.26M | 4.92M | 6.09M | 7.36M | 6.42M | 4.9M | 5.68M | 5.25M | 5.21M | 5.25M | 5.05M | 4.79M | 4.86M | 3.92M | 4.28M | 4.45M | 3.63M | 3.12M | 2.91M | 3.23M | 3.76M | 3.22M | 3.1M | 21.07M | 3.01M | 3.02M | 3.11M | 3.74M | 3.73M | 3.59M | 2.92M | 2.97M | 3.47M | 4.26M | 3.44M | 4.06M | 3.54M | 7.4M | 3.74M | 3.37M | 4.38M |
| Research and Development Revenue Growth | +47.49% | -19.20% | -17.25% | +14.72% | +30.95% | -13.65% | +8.05% | +0.79% | -0.63% | +3.94% | +5.30% | -1.40% | +23.85% | -8.40% | -3.71% | +22.56% | +16.42% | +7.04% | -9.70% | -14.27% | +16.97% | +3.91% | -85.31% | +600.47% | -0.33% | -3.05% | -16.74% | +0.27% | +3.96% | +22.88% | -1.75% | -14.31% | -18.58% | +23.67% | -15.16% | +14.76% | -52.24% | +97.97% | +11.01% | -23.03% | n/a |